Royalty Pharma RPRX
NASDAQ RPRX
$69.31 +0.34 (+0.49%)
At close: Nov 13, 2026 · 4:00 PM EST

Royalty Pharma (RPRX) Sale of AFS Securities (2020 - 2026)

Updated

Royalty Pharma's Sale of AFS Securities was $20.74 million in Q3 2026, compared with -$52.48 million a year earlier and up 380.1% from the prior quarter.

Analysis

Royalty Pharma (RPRX) Sale of AFS Securities (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Royalty Pharma's Sale of AFS Securities was $32.26 million through Sep 30, 2026; for FY2025, it was $21.23 million, up 7.3% from FY2024.

  • Sale of AFS Securities shows a five-year compound annual growth rate of 47.9% (FY2020 to FY2025).
  • In earlier years, Sale of AFS Securities was $19.79 million in FY2024, $1.44 million in FY2023 (-99.7%), $542.04 million in FY2022 (+767.3%) and $62.5 million in FY2021.
  • The Q3 2026 figure marks the highest quarterly Sale of AFS Securities since Q2 2025.
  • Compared with a year earlier, Sale of AFS Securities was higher in two of the last five quarters, with growth averaging 264.2%.
  • The best year-over-year quarter for Sale of AFS Securities over five years was Q1 2025 (growth of 774.0%); the worst was Q4 2023 (a decline of 99.7%).
  • Per Business Quant data, RPRX's Sale of AFS Securities in the three quarters before Q3 2026 was $4.32 million (Q2 2026), $4.32 million (Q1 2026) and $2.88 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sale of AFS Securities (Qtr)
1 Royalty Pharma 39.80 Bn 40.13 Bn - 20.74 Mn
2 Rocket Companies 38.90 Bn 27.72 Bn - -
3 Orix 38.66 Bn 9.30 Bn 13.83 Bn -
4 Federal National Mortgage Association Fannie Mae 26.46 Bn -16,107.65 Bn - 99.00 Mn
5 Synchrony Financial 22.47 Bn -45.15 Bn - -
6 Affirm Holdings 22.07 Bn 15.11 Bn - -
7 Royal Gold 21.71 Bn 20.92 Bn 402.46 Mn -
8 Ares Capital 13.84 Bn 11.59 Bn - -
9 Annaly Capital Management 13.83 Bn 4.86 Bn - 4.00 Bn
10 Federal Home Loan Mortgage 12.64 Bn -328.33 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 20.74 Mn
Jun 30, 2026 4.32 Mn
Mar 31, 2026 4.32 Mn
Dec 31, 2025 2.88 Mn
Sep 30, 2025 -52.48 Mn
Jun 30, 2025 27.42 Mn
Mar 31, 2025 12.59 Mn
Dec 31, 2024 12.59 Mn
Sep 30, 2024 2.88 Mn
Jun 30, 2024 200,000.00
Mar 31, 2024 1.44 Mn
Dec 31, 2023 1.44 Mn
Jun 30, 2023 -82.90 Mn
Dec 31, 2022 495.17 Mn
Sep 30, 2022 15.63 Mn
Jun 30, 2022 15.63 Mn
Mar 31, 2022 15.63 Mn
Dec 31, 2021 15.63 Mn
Sep 30, 2021 15.63 Mn
Jun 30, 2021 15.63 Mn
API Access

Royalty Pharma Sale of AFS Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-of-afs-securities&ticker=RPRX&period=max&api_key=YOUR_API_KEY